A Second-Generation MicroRNA-Based Assay for Diagnosing Tumor Tissue Origin

The abilities of the assay to identify 42 tumor types with high accuracy and to maintain the same performance in samples from patients clinically diagnosed with CUP promise improved utility in the diagnosis of cancers of unknown/uncertain primary origins.